Nutrition Research
Volume 30, Issue 1 , Pages 74-81, January 2010

Inhibition by licorice flavonoid oil of glutathione S-transferase–positive foci in the medium-term rat hepatocarcinogenesis bioassay

  • Kaku Nakagawa

      Affiliations

    • QOL Division, Kaneka Corporation, Kita-ku, Osaka 530-8288, Japan
  • ,
  • Kazunori Hosoe

      Affiliations

    • QOL Division, Kaneka Corporation, Kita-ku, Osaka 530-8288, Japan
  • ,
  • Takayoshi Hidaka

      Affiliations

    • Department of Health Sciences and Social Pharmacy, Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Chuo-ku, Kobe 650-8586, Japan
  • ,
  • Kyoko Nabae

      Affiliations

    • DIMS Institute of Medical Science, Inc., Azai-cho, Ichinomiya, Aichi 491-0113, Japan
  • ,
  • Mayumi Kawabe

      Affiliations

    • DIMS Institute of Medical Science, Inc., Azai-cho, Ichinomiya, Aichi 491-0113, Japan
  • ,
  • Mitsuaki Kitano

      Affiliations

    • Pharmacology and Toxicology Laboratory, Frontier Biochemical and Medical Research Laboratories, Kaneka Corporation, Takasago, Hyogo 676-8688, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 79 445 2427; fax: +81 79 445 2699.

Received 19 October 2009; received in revised form 5 December 2009; accepted 17 December 2009.

Abstract 

Licorice flavonoid oil (LFO) is a new functional food ingredient consisting of hydrophobic licorice polyphenols in medium-chain triglycerides. Recently, it was reported that licorice and its derivatives have anticarcinogenic activity in some types of tumors. However, the anticarcinogenic activity has not been identified in the liver, which is a major target organ for carcinogenesis in human. Therefore, we hypothesized that LFO has antihepatocarcinogenic activity, and we tested this hypothesis using the rat medium-term liver bioassay for carcinogens. Six-week-old male F344 rats (15 animals/group) received N-diethylnitrosamine (200 mg/kg by intraperitoneal injection) to initiate carcinogenesis. From the second week after initiation, animals received a 6-week regimen of either LFO concentrate solution (0, 150, 300, or 600 mg/kg) intragastrically or phenobarbital sodium salt in the diet (500 ppm) as a positive control. During the third week after initiation, animals were subjected to a two-thirds partial hepatectomy. During the eighth week of the treatment period, liver samples were taken from animals and examined immunohistochemically for expression of glutathione S-transferase placental form. No increase in the number of glutathione S-transferase placental form–positive liver foci was observed in all LFO groups compared with the negative control (solvent) group, and the number of foci in the 600 mg/kg LFO group was significantly lower than that in the negative control group. These results indicate that LFO concentrate solution has a significant inhibitory effect on liver carcinogenesis at 600 mg/kg.

Abbreviations: DEN, nitrosodiethylamine, GST-P, glutathione S-transferase placental form, LFO, licorice flavonoid oil, MCTs, medium-chain triglycerides, S.PB, phenobarbital sodium salt

Keywords: Licorice flavonoid oil, Glycyrrhiza glabra, Medium-term liver bioassay, Rat, Carcinogenesis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0271-5317(09)00255-3

doi:10.1016/j.nutres.2009.12.005

Nutrition Research
Volume 30, Issue 1 , Pages 74-81, January 2010